United States · FDA National Drug Code directory

Temazepam

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0228-2076_3050ee1e-c494-48ce-be40-6424e9661d87
Product NDC
0228-2076
Form
CAPSULE
Composition / generic term
Temazepam
Labeler
Actavis Pharma, Inc.
Marketing category
ANDA
Marketing start / end (source format)
19900930
Source listing expiry
20261231

Source-listed ingredients

  • TEMAZEPAM — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE in 1 BOTTLE (0228-2076-10) · 0228-2076-10
  • 500 CAPSULE in 1 BOTTLE (0228-2076-50) · 0228-2076-50

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →